Skip to main content

Table 2 Independent risk factors for carba-NS GNB bacteremiaa

From: Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia

Variables

aOR (95% CI)

P

Carbapenem use at the onset of GNB bacteremia

91.2 (29.3–284.1)

< 0.001

Isolation of CRAB in the prior 1 year

19.4 (3.4–112.5)

0.001

Days from chemotherapy to GNB bacteremia

1.1 (1.1–1.2)

< 0.001

  1. aOR adjusted odds ratio, CI confidence interval, GNB gram negative bacilli, CRAB carbapenem resistant Acinetobacter baumannii
  2. a Following variables were included in the backward stepwise logistic regression: age, induction or re-induction chemotherapy, carbapenem use at bacteremia onset, isolation of vancomycin-resistant enterococci, extended-spectrum β-lactamase-producing enterobacteriaceae, or CRAB in the prior year, preceding bacteremia during the hospitalization, and days from chemotherapy to GNB bacteremia